Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

GAIN vs CCAP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GAIN Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 9–1 Matrix Metrics)

GAIN Overall Winner 6-Pillar Tally: GAIN 3 – 2 CCAP (1 Tie) Matrix Metrics: GAIN 9 – 1 CCAP

As of Nov 16, 2026, Gladstone Investment Corporation (GAIN) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GAIN carries a Unified Composite Score of 39.9/100 (SELL) at $14.61 (16.8x Forward P/E, 94.4% operating margin), whereas CCAP carries 19.6/100 (STRONG SELL) at $10.08 (6.9x Forward P/E, 78.4% operating margin).

  • Defensive Composite Rating Caution: Although GAIN compares more favorably head-to-head, both GAIN (39.9/100 SELL) and CCAP (19.6/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: GAIN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.7); meanwhile CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GAIN vs CCAP
GAIN NASDAQ Head-to-Head Winner
Gladstone Investment Corporation
Institutional Equity
$14.61
-1.81% 1D
Market Cap $582.6M
TTM Revenue $104M
Forward P/E 16.8x
Beta / 30D Vol 0.55β · 21% Vol
Unified Composite Score
39.9 / 100 SELL
Tech 46.0 Fund 50.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.6%), weak momentum, RSI 39
RSI-14: 38.7 · SMA20: $14.97 · SMA50: $15.37
CCAP NASDAQ
Crescent Capital BDC, Inc. Common stock
Institutional Equity
$10.08
-0.49% 1D
Market Cap $373.2M
TTM Revenue $156M
Forward P/E 6.9x
Beta / 30D Vol 0.44β · 50% Vol
Unified Composite Score
19.6 / 100 STRONG SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 61
RSI-14: 61.3 · SMA20: $9.36 · SMA50: $9.42

6-Pillar Scorecard Institutional Category Breakdown (GAIN 3 – 2 CCAP)

Columns: Metric · GAIN · CCAP
1. Valuation Multiples CCAP
Forward P/E 16.8x 6.9x
Trailing P/E 3.8x 7.4x
PEG Ratio 5.41x 0.89x
EV / Revenue 5.6x 2.4x
2. Growth & Scale GAIN
Revenue Growth (YoY) +20.4% -15.5%
Earnings Growth (YoY) +326.5% -14.9%
TTM Revenue (USD) $104M $156M
Market Cap $582.6M $373.2M
3. Profitability & Quality GAIN
Gross Margin 100.0% 100.0%
Operating Margin 94.4% 78.4%
Net Profit Margin 158.9% -2.0%
Return on Equity (ROE) 29.2% -0.5%
4. Balance Sheet & Cash Flow GAIN
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $16.78 Book/Sh · 29.2% ROE $19.10 Book/Sh · -0.5% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 12.6% (<1st %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CCAP
OpEx & R&D Intensity 5.6% of Rev ($5.8M) 21.6% of Rev ($34M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Asset Management Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GAIN (9) vs CCAP (1)
Institutional Metric GAIN CCAP Criterion Row Edge
Market Capitalization
Scale
$582.6M $373.2M Larger Scale GAIN
Trailing P/E Ratio
Valuation
3.8x 7.4x Lower Multiple GAIN
Forward P/E Ratio
Valuation
16.8x 6.9x Lower Multiple CCAP
Revenue Growth (YoY)
Growth
+20.4% -15.5% Higher Growth GAIN
Operating Margin (TTM)
Profitability
94.4% 78.4% Higher Margin GAIN
Net Profit Margin
Profitability
158.9% -2.0% Higher Margin GAIN
Return on Equity (ROE)
Capital Efficiency
29.2% -0.5% Higher ROE GAIN
52-Week Range Position
Momentum
37% ($13–$17) 25% ($8–$15) Stronger Trend GAIN
Beta / 30D Volatility
Risk Regime
0.55β · 21% Vol 0.44β · 50% Vol Lower Realized Risk GAIN
Unified Institutional Score
Composite Signal
39.9 / 100 (SELL) 19.6 / 100 (STRONG SELL) Higher Composite GAIN
Trailing 12M Revenue (USD)
Operating Scale
$104M $156M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
5.41x PEG · 5.6x EV/Rev 0.89x PEG · 2.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($16.78 Book/Sh · 29.2% ROE) N/A ($19.10 Book/Sh · -0.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CCAP +16.18 pp
GAIN: -2.92% · CCAP: +13.26%
3M Horizon CCAP +2.86 pp
GAIN: -9.7% · CCAP: -6.84%
6M Horizon CCAP +1.5 pp
GAIN: -10.53% · CCAP: -9.03%
1Y Horizon GAIN +31.39 pp
GAIN: +5.56% · CCAP: -25.83%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GAIN vs CCAP. Trailing 12-month operating profitability (GAIN 94.4% vs CCAP 78.4%) and valuation multiples (GAIN 16.8x vs CCAP 6.9x Forward P/E) are benchmarked directly in Pillar 4 below.

GAIN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$104M
Gross Margin100.0%
Op. Margin94.4%
ROE / Fwd P/E29.2% · 16.8x
CCAP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$156M
Gross Margin100.0%
Op. Margin78.4%
ROE / Fwd P/E-0.5% · 6.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GAIN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 12.6%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GAIN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CCAP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CCAP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GAIN Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $582.6M market capitalization and 94.4% operating margin.
OpEx & R&D Reinvestment 5.6% of Rev ($5.8M)
90D Engineering Disclosures 0 Published
CCAP Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $373.2M market capitalization and 78.4% operating margin.
OpEx & R&D Reinvestment 21.6% of Rev ($34M)
90D Engineering Disclosures 0 Published

Investor FAQ GAIN vs CCAP Key Questions & Quantitative Answers

As of Nov 16, 2026, Gladstone Investment Corporation (GAIN) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GAIN carries a Unified Composite Score of 39.9/100 (SELL) at $14.61 (16.8x Forward P/E, 94.4% operating margin), whereas CCAP carries 19.6/100 (STRONG SELL) at $10.08 (6.9x Forward P/E, 78.4% operating margin). Defensive Composite Rating Caution: Although GAIN compares more favorably head-to-head, both GAIN (39.9/100 SELL) and CCAP (19.6/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: GAIN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.7); meanwhile CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GAIN leads the Growth & Scale pillar: GAIN posts +20.4% YoY revenue growth and +326.5% YoY earnings growth on $104M TTM revenue (100.0% gross margin, 94.4% operating margin), compared with CCAP at -15.5% YoY revenue growth and -14.9% YoY earnings growth on $156M TTM revenue (100.0% gross margin, 78.4% operating margin). On trailing 12-month operating scale, GAIN generates $104M in USD-normalized revenue versus $156M for CCAP. In operating R&D and SG&A reinvestment, GAIN deploys 5.6% of Rev ($5.8M) (0 90-day corporate R&D disclosures) versus 21.6% of Rev ($34M) (0 disclosures) for CCAP.

CCAP screens cheaper on headline valuation multiples. GAIN trades at 16.8x Forward P/E, 3.8x Trailing P/E, 5.41x PEG, and 5.6x EV/Revenue (unreported cash flow margin), whereas CCAP trades at 6.9x Forward P/E, 7.4x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GAIN (29.2% ROE) versus CCAP (-0.5% ROE) capital efficiency.

In options market volatility and institutional positioning, GAIN carries 12.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.55β · 21% Vol realized risk). By comparison, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 50% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.